Q07817 (B2CL1_HUMAN) Homo sapiens (Human)

Bcl-2-like protein 1 UniProtKBInterProSTRINGInteractive Modelling

233 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; ) Identical sequences: Vulpes vulpes: A0A3Q7R8S3; Canis lupus familiaris: Q76LT7; Homo sapiens: A0A0S2Z3C5; Pongo abelii: A0A6D2VXZ3; A0A2J8VIH3; Pan troglodytes: H2QK53; A0A6D2VVP1; Pan paniscus: A0A2R8Z9D7; Gorilla gorilla gorilla: G3RY91

Sequence Features

 210-226Helical
 61-62Cleavage; by caspase-1
 1-26Apoptosis regulator, Bcl-2 protein, BH4
IPR003093PF02180
 90-188Blc2 family
IPR026298PF00452

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE Heteromer
Q16611;
1bxl1-210
Solution structure of BCL-XL bound to P73-TAD peptide Heteromer
O15350;
6ijq1-209
Solution structure of BCL-xL in complex with PUMA BH3 peptide Heteromer
Q9BXH1;
2m041-209
SOLUTION STRUCTURE OF AN APOPTOSIS ACTIVATING PHOTOSWITCHABLE BAK PEPTIDE BOUND to BCL-XL Heteromer
Q16611;
33B;2lp81-209
COMPLEX OF BCL-XL WITH PEPTIDE FROM BAD Heteromer
Q92934;
1g5j1-209
TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL Heteromer
P13693;
BCT;NA;4z9v1-208
Bcl-xL with mouse Bak BH3 Q75L complex Heteromer
O08734;
EDO;5fmj1-208
Crystal structure of alpha-beta-foldamer 2c in complex with Bcl-xL Heteromer
O43521;
CL;SO4;4a1u1-206
Bcl-xL with Bak BH3 complex Heteromer
Q16611;
GOL;5fmk2-207
Crystal structure of BCL-XL in complex with inhibitor (WEHI-539) Heteromer
X0B;EDO;SO4;3zlr1-203
Puma BH3 foldamer in complex with Bcl-xL Heteromer
2yj11-202
Crystal structure of Bcl-xL in complex with HBx-BH3 motif Heteromer
I3XMW8;
5b1z1-200
Bcl-xL complex with Beclin 1 BH3 domain T108D Heteromer
Q14457;
CL;6dco1-198
Solution Structure of the Complex Between BCL-xL and the p53 Core Domain determined with PRE restra… Heteromer
P04637;
ZN;2mej1-198
Bcl-xL in complex with Bim-h3Pc-RT Heteromer
O43521;
EDO;5vx31-197
BimL12F in complex with Bcl-xL Heteromer
O43521;
ZN;3io81-197
Bcl-xL complex with Beclin 1 BH3 domain T108pThr Heteromer
Q14457;
6dcn1-197
Crystal structure of alpha-beta foldamer 4c in complex with Bcl-xL Heteromer
O43521;
4a1w1-197
Structure of the Bcl-XL:Beclin 1 complex Heteromer
Q14457;
2p1l2-198
Structure of Bcl-xL bound to BimSAHB Heteromer
O43521;
14×GOL;2yq61-196
Structure of Bcl-xL bound to BimLOCK Heteromer
O43521;
GOL;2yq71-196
Complex of Bcl-xL with its BH3 domain Heteromer
CA;EPE;EDO;4cin2-197
Crystallographic structure of BCL-xL domain-swapped dimer in complex with PUMA BH3 peptide at 2.9A … Heteromer
Q9BXH1;
4hnj1-196
Solution structure of the Bcl-xL/Beclin-1 complex Heteromer
Q14457;
2pon1-196
Crystal structure of Bcl-xL in complex with BIM BH3 domain Heteromer
O43521;
4qvf2-196
Bcl-xL bound to alpha beta Puma BH3 peptide 5 Heteromer
Q9BXH1;
15×CD;EDO;4bpk1-195
Crystal structure of Bcl-xL in complex with BID BH3 domain Heteromer
P55957;
IMD;4qve4-198
Bim BH3 peptide in complex with Bcl-xL Heteromer
O43521;
3fdl1-194
Crystal structure of human SOUL BH3 domain in complex with Bcl-xL Heteromer
Q9Y5Z4;
SO4;3r854-197
Crystal structure of Bcl-xL in complex with the BaxBH3 domain Heteromer
Q07812;
3pl73-196
Structure of human Bcl-2 in complex with PUMA BH3 peptide Heteromer
P10415; Q9BXH1;
6qg814-178
Affimer:BclxL Heteromer
6hjl83-197
Crystal structure of Bcl-xl bound to BIM-MM Heteromer
O43521; Q64373;
5c3g168-196
Bcl-2 complex with Beclin 1 T108D BH3 domain Heteromer
P10415; Q14457;
5vay29-44
Bcl-2 alpha beta-1 LINEAR complex Heteromer
O43521; P10415;
5agx29-44
Bcl-2 alpha beta-1 complex Heteromer
O43521; P10415;
5agw29-44
Crystal structure of Bcl-xL hexamerhomo-6-mer GOL;4ppi3-196
Crystal structure of Bcl-xL in complex with benzoylurea compound (42)homo-4-mer X0R; 12×SO4; 20×EDO;4c5d1-198
Bcl-XL 3D Domain Swapped Dimerhomo-2-mer 2b481-200
Crystal structure of Bcl-xL in complex with benzoylurea compound (39b)homo-2-mer X0D;SO4; 12×EDO;4c521-198
alpha/beta foldamer in complex with Bcl-xLhomo-2-mer 11×EDO;3fdm1-198
Bcl-xL in complex with inhibitor (Compound 10)homo-2-mer 38H;EDO;ACT;4tuh1-196
Crystal structure of BCL-XL in complex with W1191542homo-2-mer X0J; 11×EDO;CL;3inq1-196
Discovery of a Potent and Selective BCL-XL Inhibitor That Demonstrates Thrombocytopenia and Inhibit…homo-2-mer 3CQ;4qvx2-196
BCL-XL in a complex with a covalent small molecule inhibitorhomo-2-mer KBH;BR;6rnu2-196
Crystal structure of Bcl-xL in complex with compound 10homo-2-mer LC6;PO4;3wiz3-196
NMR STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH, MINIMIZED AVERAGE STRUCTUREmonomer 1lxl1-210
Solution structure of a Bcl-xL S62E mutantmonomer 6bf21-209
Solution structure of BCL-xL determined with selective isotope labelling of I,L,V sidechainsmonomer 2m031-209
Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based l…monomer 43B;2o1y1-209
Solution Structure of BCL-xL in its p53-bound conformation determined with selective isotope labell…monomer 2me81-209
Solution structure of BCL-xL containing the alpha1-alpha2 disordered loop determined with selective…monomer 2me91-209
NMR STRUCTURE of Bcl-XLmonomer 2lpc1-209
Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based l…monomer N3B;1ysi1-209
Solution structure of the anti-apoptotic protein Bcl-xL complexed with an acyl-sulfonamide-based li…monomer 43B;1ysn1-209
Solution Structure of the Anti-apoptotic Protein Bcl-xL in Complex with "SAR by NMR" Ligandsmonomer 4FC;TN1;1ysg1-209
Crystal Structure of Bcl-xL bound to BM903monomer 03B;ZN;ACT;3sp71-199
Crystal Structure of Bcl-xL bound to BM501monomer B50;GOL;3spf1-197
Structure of human Bcl-2 in complex with ABT-263monomer 1XJ;6qgh14-210
Human Bcl-XL containing a Phe to Leu mutation at position 146monomer 1r2i1-197
Crystal structure of BCL-XL in complex with inhibitor (Compound 3)monomer H0Y;SO4;EDO;3zln1-197
The Crystal Structure of human Bcl-2-like protein 1 from Wuxi Biortus.monomer SO4;7ca41-197
Structure of Human Bcl-XL at 1.95 Angstromsmonomer 1r2d1-196
X-RAY STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATHmonomer 1maz1-196
Human Bcl-XL containing an Ala to Leu mutation at position 142monomer 1r2h1-196
Crystal structure of Bcl-xL in complex with inhibitor (Compound 2).monomer H1I;3zk62-197
Crystal structure of BCL-XL in complex with inhibitor (Compound 6)monomer X8U;3zlo2-197
Human Bcl-XL containing a Phe to Trp mutation at position 97monomer 1r2g1-196
Crystal structure of Bcl-Xl complex with 4-(5-butyl-3-(hydroxymethyl)-1-phenyl-1h-pyrazol-4-yl)-3-(…monomer 0Q5;IMD;4ehr2-196
Human Bcl-XL containing a Glu to Leu mutation at position 92monomer 1r2e2-196
Human Bcl-xL containing a Trp to Ala mutation at position 137monomer 3cva2-196
Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based l…monomer LI0;2o2m2-196
Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based l…monomer LIW;2o2n2-196
Structure of human Bcl-2 in complex with fragment/ABT-263 hybridmonomer J1T;6qgj14-207
Crystal structure of Bcl-xL in complex with a Quinazoline sulfonamide inhibitormonomer HI0;CL;GOL;3qkd4-197
Crystal structure of Bcl-xL in complex with ABT-737monomer CL;N3C;GOL;2yxj4-197
Structure of human Bcl-2 in complex with THIQ-phenyl pyrazole compoundmonomer J1Q;ACT;6qgk14-204
Structure of human Bcl-2 in complex with analogue of ABT-737monomer J1H;6qgg14-178
Crystal structure of Bcl-2 in complex with the novel orally active inhibitor S55746monomer F3Q;6gl828-95
HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITORmonomer 398;4aq329-91
Structure of the transmembrane helix of BclxL in phospholipid nanodiscsmonomer 6f46202-233
Structure of the C-terminal domain of BCL-XL in membranemonomer 6x7i206-233
crystal structure of BCL-2 with venetoclaxmonomer LBM;2PE;6o0k29-44
crystal structure of BCL-2 F104L mutation with venetoclaxmonomer LBM;PEG;6o0m29-44
crystal structure of BCL-2 G101A mutation with venetoclaxmonomer LBM;PEG;6o0p29-44
crystal structure of BCL-2 G101V mutation with S55746monomer F3Q;6o0o29-44
Crystal Structure of human Bcl-2 in complex with a small molecule inhibitor targeting Bcl-2 BH3 dom…monomer 1E9;4ieh29-44
crystal structure of BCL-2 G101V mutation with venetoclaxmonomer LBM;PEG;CL;6o0l29-44

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
2monomer-2.311r2d.1.A1-133
100.00